DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
11.89
-0.87 (-6.82%)
At close: Dec 12, 2025, 4:00 PM EST
11.90
+0.01 (0.08%)
After-hours: Dec 12, 2025, 7:03 PM EST
DarioHealth Revenue
DarioHealth had revenue of $5.01M in the quarter ending September 30, 2025, a decrease of -32.55%. This brings the company's revenue in the last twelve months to $24.73M, up 7.29% year-over-year. In the year 2024, DarioHealth had annual revenue of $27.04M with 32.86% growth.
Revenue (ttm)
$24.73M
Revenue Growth
+7.29%
P/S Ratio
1.44
Revenue / Employee
$122,436
Employees
202
Market Cap
80.47M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 27.04M | 6.69M | 32.86% |
| Dec 31, 2023 | 20.35M | -7.30M | -26.41% |
| Dec 31, 2022 | 27.66M | 7.14M | 34.82% |
| Dec 31, 2021 | 20.51M | 12.94M | 170.76% |
| Dec 31, 2020 | 7.58M | 17.00K | 0.22% |
| Dec 31, 2019 | 7.56M | 165.00K | 2.23% |
| Dec 31, 2018 | 7.39M | 2.22M | 43.02% |
| Dec 31, 2017 | 5.17M | 2.37M | 84.45% |
| Dec 31, 2016 | 2.80M | 1.98M | 240.58% |
| Dec 31, 2015 | 823.00K | 772.00K | 1,513.73% |
| Dec 31, 2014 | 51.00K | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
DRIO News
- 3 days ago - Dario Launches DarioIQ™ AI Integration in Dario Health App with Direct-to-Consumer First Version for Hypertension Members - PRNewsWire
- 9 days ago - Dario's Data-Driven Digital Health Platform Delivers Significant and Sustainable Improvements in Blood Pressure: Findings Published in JMIR Cardio - PRNewsWire
- 11 days ago - DarioHealth Far Exceeds 2025 New Client Target with 79 New Accounts Signed Year-to-Date - PRNewsWire
- 19 days ago - DarioHealth Announces Publication of Sanofi Study in JMIR Demonstrating an Estimated $5,077 Medical Cost Savings Per Dario Digital Health Platform User Per Year - PRNewsWire
- 4 weeks ago - DarioHealth Corp. (DRIO) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - DarioHealth Reports Third Quarter 2025 Financial and Operating Results - PRNewsWire
- 4 weeks ago - DarioHealth Presents New Data Demonstrating Significant Reduction in Medical Costs Among Employer Populations Using Its Digital Health Platform - PRNewsWire
- 5 weeks ago - DarioHealth to Report Third Quarter 2025 Results on Thursday, November 13, 2025 - PRNewsWire